Sanofi loses Lantus patent claims against Mylan

U.S. generics drugmaker Mylan N.V. said on Thursday the U.S. Patent and Trademark Office rejected French pharma company Sanofi's patent infringement claims related to two formulations of its blockbuster insulin drug Lantus.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news